The global pregnancy care products market size was valued at USD 22.39 million in 2017. Rising demand stemming from developing countries is one of the principal factors driving the global market towards growth.
A gradual shift in trend from traditional home remedies for skincare during pregnancy to commercially available products has been observed over the past few years. In addition, the rising awareness is driving the attention of consumers towards use of safer and more effective skincare solutions. The market for organic variants of pregnancy care products is on a global rise.
Rising R&D is resulting in introduction of newer variants that are more effective and safer. This has resulted in the introduction of safer organic alternatives, leading to a paradigm shift from chemical-based pregnancy care products to herbal/organic variants.
Along with safety concerns during pregnancy, expecting mothers also focus on skincare and physical appearance post pregnancy, which is encouraging adoption of pregnancy care products. Discomfort caused during pregnancy has become a major issue for women across the globe.
Extensive campaigns of market players to influence consumers through social media are also propelling the penetration and adoption of these products. Consumers often rely on social media when making a choice for skincare products. As a result, major market players are involved in heavy investments in advertising campaigns to boost product penetration and market positioning.
On the other hand, health hazards related to use of chemical products during pregnancy and declining birth rate across the globe are challenging the growth of the overall market.
Stretchmark minimizers emerged as the largest segment in the global market in 2017. High usage of stretchmark minimizers as a preventive measure is one of the key factors contributing to the segment’s dominance. Increasing awareness regarding pregnancy care over the forecast period is anticipated to propel market growth.
The breast cream segment is expected to exhibit the fastest growth rate in the pregnancy care products market. This is associated with rising concerns of breast health during pregnancy and during lactation period. A woman undergoes several physiological changes during pregnancy, including change in breast size, especially during the first trimester. Proper breast care is strongly advised during gestation period to ensure proper feeding after delivery. Improper care may lead to problems such as elasticity, sagging, and flattening of breasts.
Breast creams intended for use during pregnancy contain omega 3 fatty acids and antioxidants, which help retain skin and hydrate, elasticize, and strengthen breasts. These benefits, along with increasing awareness among pregnant women, are likely to up the adoption of breast creams.
Various other issues associated with pregnancy include skin irritation, sore breasts, and leg pain. As a result, demand for pregnancy care products such as stressed leg creams, lotions, and gels, nipple protection cream, and body restructuring products is increasing.
The global market is dominated by Asia Pacific and the region is expected to retain its dominance throughout the forecast period. Rising demand for pregnancy care products, increasing disposable income, higher birth rate, and growing awareness among would-be parents are key factors contributing toward regional growth.
Countries such as India, China, and Japan have a large population base, which makes the customer base for these products much larger. The region has been witnessing a paradigm shift in customer buying behavior with increasing disposable income. Aggressive marketing undertaken by companies to raise awareness levels is also catalyzing growth.
Latin America and MEA are expected to exhibit a significant growth rate over the forecast period owing to rising concerns over pre-natal and post-natal care. This, coupled with increasing birth rate, is likely to boost adoption of pregnancy care products in the region.
The global market is highly competitive. Key players include Mama Mio U.S. Inc.; Clarins Group; Novena Maternity; E.T. Browne Drug Co., Inc.; Expanscience Laboratories, Inc.; and Noodle & Boo.
Key parameters affecting competition are rapid adoption of advanced treatment options and rising need for optimum capital utilization. In addition, major players are engaging in extensive marketing campaigns to retain their market share and diversify their portfolio.
Attribute |
Details |
Base year for estimation |
2017 |
Actual estimates/Historical data |
2014 - 2016 |
Forecast period |
2018 - 2025 |
Market representation |
Revenue in USD Million and CAGR from 2017 to 2025 |
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Country scope |
U.S., Canada, U.K., Germany, China, India, Mexico, Brazil, South Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
15% free customization scope (equivalent to 5 analyst working days) |
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global pregnancy care products market report based on product and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
Stretch Mark Minimizer
Breast Cream
Toning/Firming Lotion
Itching Prevention Cream
Nipple Protection Cream
Body Restructuring Gel
Stressed Leg Product
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
The U.S.
Canada
Europe
The U.K.
Germany
Asia Pacific
India
China
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
Multiple therapeutic regimens are being followed across the globe in attempts to come up with a reliable treatment for Covid-19. One line of treatment includes the use of hydroxychloroquine, while a second treatment line focuses to use antiviral drugs used in the disease management of HIV. Both these approaches have surged demand from advanced antivirals and antimalarial drugs. This impacts the drug manufacturers as an off label indication for these drug classes has to be worked upon. At the moment, the WHO has not prescribed any of these approaches, neither they have commented if one is better than the other. The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.